Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies.

Mannheimer JD, Duval DL, Prasad A, Gustafson DL.

BMC Med Genomics. 2019 Jun 17;12(1):87. doi: 10.1186/s12920-019-0519-2.

2.

Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.

Das S, Idate R, Cronise KE, Gustafson DL, Duval DL.

Mol Cancer Ther. 2019 Aug;18(8):1460-1471. doi: 10.1158/1535-7163.MCT-18-1346. Epub 2019 Jun 7.

PMID:
31175136
3.

Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.

Cronise KE, Hernandez BG, Gustafson DL, Duval DL.

Mol Pharmacol. 2019 Jul;96(1):36-46. doi: 10.1124/mol.119.115808. Epub 2019 May 2.

PMID:
31048548
4.

Canine sarcomas as a surrogate for the human disease.

Gustafson DL, Duval DL, Regan DP, Thamm DH.

Pharmacol Ther. 2018 Aug;188:80-96. doi: 10.1016/j.pharmthera.2018.01.012. Epub 2018 Mar 9. Review.

5.

The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

Fowles JS, Dailey DD, Gustafson DL, Thamm DH, Duval DL.

Vet Comp Oncol. 2017 Jun;15(2):481-492. doi: 10.1111/vco.12192. Epub 2016 May 19.

6.

Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.

Fowles JS, Brown KC, Hess AM, Duval DL, Gustafson DL.

BMC Bioinformatics. 2016 Feb 19;17:93. doi: 10.1186/s12859-016-0942-8.

7.

DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.

Dailey DD, Ehrhart EJ, Duval DL, Bass T, Powers BE.

J Vet Diagn Invest. 2015 May;27(3):268-77. doi: 10.1177/1040638715578878. Epub 2015 Apr 10.

PMID:
25862711
8.

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.

Halsey CH, Gustafson DL, Rose BJ, Wolf-Ringwall A, Burnett RC, Duval DL, Avery AC, Thamm DH.

BMC Vet Res. 2014 May 6;10:105. doi: 10.1186/1746-6148-10-105.

9.

Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.

Kalet BT, Anglin SR, Handschy A, O'Donoghue LE, Halsey C, Chubb L, Korch C, Duval DL.

PLoS One. 2013 Jul 9;8(7):e68815. doi: 10.1371/journal.pone.0068815. Print 2013.

10.

HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.

Dailey DD, Anfinsen KP, Pfaff LE, Ehrhart EJ, Charles JB, Bønsdorff TB, Thamm DH, Powers BE, Jonasdottir TJ, Duval DL.

BMC Vet Res. 2013 Jul 1;9:130. doi: 10.1186/1746-6148-9-130.

11.

Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation.

O'Donoghue LE, Rivest JP, Duval DL.

J Vet Diagn Invest. 2011 Jul;23(4):780-5. doi: 10.1177/1040638711408064. Epub 2011 Jun 13.

PMID:
21908323
12.

Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.

Angstadt AY, Motsinger-Reif A, Thomas R, Kisseberth WC, Guillermo Couto C, Duval DL, Nielsen DM, Modiano JF, Breen M.

Genes Chromosomes Cancer. 2011 Nov;50(11):859-74. doi: 10.1002/gcc.20908. Epub 2011 Aug 11.

PMID:
21837709
13.

PRKA/AMPK: integrating energy status with fertility in pituitary gonadotrophs.

Duval DL.

Biol Reprod. 2011 Feb;84(2):205-6. doi: 10.1095/biolreprod.110.089722. Epub 2010 Nov 17. No abstract available.

PMID:
21084710
14.

Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.

O'Donoghue LE, Ptitsyn AA, Kamstock DA, Siebert J, Thomas RS, Duval DL.

BMC Cancer. 2010 Sep 22;10:506. doi: 10.1186/1471-2407-10-506.

15.

An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis.

Sottnik JL, Duval DL, Ehrhart EJ, Thamm DH.

Clin Exp Metastasis. 2010 Mar;27(3):151-60. doi: 10.1007/s10585-010-9318-z. Epub 2010 Mar 7.

PMID:
20213324
16.

A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.

Jean A, Gutierrez-Hartmann A, Duval DL.

Mol Endocrinol. 2010 Jan;24(1):91-103. doi: 10.1210/me.2009-0279. Epub 2009 Nov 3.

17.

The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain.

Jonsen MD, Duval DL, Gutierrez-Hartmann A.

Mol Endocrinol. 2009 Sep;23(9):1371-84. doi: 10.1210/me.2008-0137. Epub 2009 Jun 25.

18.

ETS transcription factors in endocrine systems.

Gutierrez-Hartmann A, Duval DL, Bradford AP.

Trends Endocrinol Metab. 2007 May-Jun;18(4):150-8. Epub 2007 Mar 26. Review.

PMID:
17387021
19.

Differential utilization of transcription activation subdomains by distinct coactivators regulates Pit-1 basal and Ras responsiveness.

Duval DL, Jonsen MD, Diamond SE, Murapa P, Jean A, Gutierrez-Hartmann A.

Mol Endocrinol. 2007 Jan;21(1):172-85. Epub 2006 Oct 4.

PMID:
17021049
21.
22.

Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding.

Augustijn KD, Duval DL, Wechselberger R, Kaptein R, Gutierrez-Hartmann A, van der Vliet PC.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12657-62. Epub 2002 Sep 19.

23.

PRL-releasing peptide stimulation of PRL gene transcription--enter AKT.

Duval DL, Gutierrez-Hartmann A.

Endocrinology. 2002 Jan;143(1):11-2. Review. No abstract available.

PMID:
11751585
24.
25.
29.
30.

Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione.

Duval DL, Sieg DJ, Billings RE.

Arch Biochem Biophys. 1995 Feb 1;316(2):699-706.

PMID:
7532384
31.
32.

The determination of myeloperoxidase activity in liver.

Duval DL, Howard D, McCalden TA, Billings RE.

Life Sci. 1990;47(24):PL145-50.

PMID:
2176263
33.

Atherosclerotic coronary-artery aneurysms. Report of five cases diagnosed by cine-coronary arteriography.

Olin R, Duval DL, Dickson DN.

Minn Med. 1976 Mar;59(3):157-63. No abstract available.

PMID:
1256423
34.

Effects of monoamine oxidase inhibitors, glyceryl gualacolate, and ethanol on experimental arterial thrombosis.

Duval DL, Didisheim P, Spittell JA Jr, Owen CA Jr.

Mayo Clin Proc. 1970 Aug;45(8):579-85. No abstract available.

PMID:
4394109
35.

Experimental arterial thrombosis: description of a method.

Duval DL, Didisheim P, Titus JL, Spittel JA Jr, Owen CA Jr.

Mayo Clin Proc. 1970 May;45(5):388-95. No abstract available.

PMID:
5443235

Supplemental Content

Loading ...
Support Center